Serono Symposia International Foundation (SSIF) 12th International Workshop on Molecular Targeted Therapy of Cancer (MTTC)

ROME, May 6, 2011 - Serono Symposia International Foundation, the CME provider for the
Medical Education initiative on Molecular Targeted Therapy of Cancer (MTTC),
will gather in Rome, on May 6-7, a team of worldwide recognized oncology
experts from different disciplines, in order to take part in the 12th
International Workshop on MTTC. This workshop, European Society for Medical
Oncology (ESMO) labeled, is designed to foster extensive discussion of the
presented data and to contribute to the improvement of molecular targeted
therapy of cancer in clinical practice.

(Logo:
www.newscom.com/cgi-bin/prnh/20100629/397361 )

The Medical Education Initiative on Molecular Targeted Therapy of Cancer
(MTTC), established in 2001 and headed by the International Education Council
(IEC), was developed to provide high quality medical education programs for
medical oncologists. Starting from the 1st MTTC International Workshop held
in 2002, the IEC created, in the form of a Core Educational Curriculum, the
scientific platform for future medical education activities with the intent
to regularly update the Core Curriculum through all MTTC activities
worldwide.

During this workshop, the experts attending will present the basic mode
of action and clinical application of various targeted therapies and will
present the latest developments in molecular cell biology in relation to
targeted cancer therapy; participants will have an update knowledge of the
basics of signal transduction, immunotherapy and angiogenesis with regard to
cancer therapy, the current issues in active and passive immunotherapy,
resistance to targeted therapy, and a rationale of novel combination
therapies for cancer.

"In targeted therapy we are more and more moving from the application of
single agents to combination therapy - said Professor Heinz Zwierzina,
Chairman of the IEC and Professor at the Universität Innsbruck Austria - and
potential combinations must be based on science and focus on biomarker
development. The challenges and accomplishments of this strategy will be
presented in this event".

In 2011, Serono Symposia International Foundation has taken a strong
commitment to medical education in oncology developing live events such as
workshops, expert meetings, preceptorships, online activities, and other
programs that will focus on key issues in oncology and on the
multidisciplinary approaches to patient management.

"As Continuing Medical Education provider, Serono Symposia International
Foundation is committed to offer its know-how in an International scenario -
said Prof. Christoph Zielinski, member of the IEC (International Education
Council) and of the Scientific Committee of Serono Symposia International
Foundation - and we are particularly proud to be able to bring together in
this scenario the leaders in the field of oncology in order to contribute to
the advancement of molecular cell biology in relation to targeted therapy of
cancer in clinical practice".

Serono Symposia International Foundation is a non-profit organization
based in Geneva (Switzerland). It was founded to disseminate the most
innovative achievements and potential developments of medical and scientific
research through conferences, training courses, online courses and
publications. In particular, it provides Continuing Medical Education for
doctors and healthcare professionals by organizing high-level scientific
programs. Over the past four decades Serono Symposia International Foundation
has organized more than 1500 international scientific congresses and
published more than 500 proceedings with the most important international
publishers.

<media>

Photo:
www.newscom.com/cgi-bin/prnh/20100629/397361

</media>

Ufficio stampa: GAS Communication, Chiara Ippoliti, Tel. +39-0668134260 - fax +39-0668134876, c.ippoliti at gascommunication.com